Eirgenix, Inc.TWSE: 6589

Announcement of the Production Line Expansion and Production Equipment at Zhubei Facility. (Budget Increase)

· Issued by Eirgenix, Inc.
Close
Today's Information

Provided by: EirGenix Inc.
SEQ_NO 2 Date of announcement 2022/08/11 Time of announcement 18:04:32
Subject
 Announcement of the Production Line Expansion
and Production Equipment at Zhubei Facility.
(Budget Increase)
Date of events 2022/08/11 To which item it meets paragraph 20
Statement
1.Type of contract:Production Line Expansion and Production Equipment.
2.Date of occurrence of the event:2022/08/11
3.Counterparty to the contract and relationship with
the Company:
  Facility construction companies and production equipment vendors.
  Relationship with the Company: None.
4.Major content of the contract (including total contract
amount, anticipated monetary amount of participation in the
investment, and start and end dates of the contract),
restrictive covenants, and other important terms and
conditions:
  Budget Increase:
   The upper limit is NT$60 million (tax included)
  The original Budget amount:
   The upper limit is NT$0.8925 billion (tax included)
  Total Budget amount:
   The upper limit is NT$0.9525 billion (tax included)
  Start and end dates of the contract:
   From the signing date to the completion acceptance date.
  Restrictive covenants: None.
  Other important terms and conditions: None.
5.Name of the professional appraisal firm or company and
its appraisal opinion:N/A
6.Name of the real property appraiser:N/A
7.Practice certificate number of the real property appraiser:N/A
8.Concrete purpose of the acquisition:
  To expand the capacity for CDMO business and
  the internal product commercialization.
  Production Line Expansion for Mammalian cell culture and
  Production Equipment at Zhubei Facility.
9.Any dissenting opinions of directors to the present
transaction:None.
10.Whether the counterparty of the current transaction is
a related party:No.
11.Date of the board of directors' resolution:2022/08/11
12.Date of ratification by supervisors or approval by the
 audit committee:2022/08/11
13.The appraisal report has a limited price, specific price,
or special price:NA
14.An appraisal report has not yet been obtained:NA
15.Reason for an appraisal report not being obtained:N/A
16.Reason for any significant discrepancy with the appraisal
reports and opinion of the CPA:N/A
17.Name of the CPA firm:N/A
18.Name of the CPA:N/A
19.Practice certificate number of the CPA:N/A
20.29.Any other matters that need to be specified:None.

Earlier from Eirgenix

All Eirgenix news releases